Getting off Wegovy without gaining weight: what the evidence says

Step 1: understand what changes in your body when semaglutide leaves it

Semaglutide is a GLP-1 receptor agonist, it mimics a gut hormone that tells the brain you have eaten enough and slows the rate at which food leaves your stomach. After your last injection, semaglutide's concentration in the body falls over roughly five weeks (its half-life is about seven days). As levels drop, the brake on appetite lifts. Hunger sensations, which many people on Wegovy describe as almost quiet, typically return, often quickly.

This is not a failure of willpower. The NHS medicines page for semaglutide notes that weight management medicines work alongside, not instead of, diet and activity changes, and when the medicine stops, the biological environment changes again. Understanding that dynamic is the starting point for planning well.

One trial that illustrates this clearly is the STEP 1 extension study: participants who discontinued the 2.4 mg weekly dose regained on average around two-thirds of their lost weight within a year, while those who continued maintained most of their reduction. That gap is not destiny, it is the cost of stopping without support structures already in place.

Step 2: lay the groundwork before your final dose

The period while still on Wegovy is actually the best time to build the habits that can hold weight steady afterwards. Appetite suppression is still doing some of the work, which makes it easier to practise smaller portions, higher protein meals and regular movement without feeling like an endurance sport.

A few things that the evidence and clinical experience point to as useful starting points: eating enough protein at each meal (it increases satiety independently of semaglutide), building in resistance exercise to preserve lean muscle mass lost during weight reduction, and establishing a rough sense of your daily food pattern so it does not feel improvised once the medicine ends.

Our guide on how to stop Wegovy without gaining weight covers the practical detail of tapering and dietary preparation in more depth, and if you are considering a gradual reduction rather than an abrupt stop, our advice on how to wean off Wegovy without gaining weight walks through that approach specifically. The broader question of maintaining progress without the medicine is also addressed if you are planning for the longer term. Every person's situation differs, and your prescriber at our clinical team can help you decide whether a taper or an abrupt stop is right for you specifically.

Step 3: manage the transition itself, and the weeks that follow

The first four to eight weeks after stopping tend to be the highest-risk window for rapid regain. Hunger returns and food becomes more rewarding again, sometimes quite suddenly. A few concrete strategies can slow that drift.

Eating regularly, rather than skipping meals and then feeling ravenous by mid-afternoon, helps. Keeping high-calorie, low-satiety foods less accessible at home removes a source of friction. Some people find that checking in with a GP, dietitian or their prescribing service at the one-month mark is useful, it catches early regain before it builds momentum.

If you find yourself gaining weight quickly despite reasonable effort, that is worth a conversation with a clinician sooner rather than later. It does not necessarily mean you need to restart treatment, but it might, and a prescriber can assess that properly. You can read about what drives weight gain after Wegovy for a fuller explanation of the mechanisms involved. The STEP 1 trial published in the New England Journal of Medicine remains the clearest evidence base for both how well semaglutide works and what tends to happen when it stops.

Step 4: be honest about whether stopping is actually the right call

Sometimes the question is not how to stop, it is whether stopping is the right decision at this point. Obesity is a chronic condition, and for many people, Wegovy is a long-term rather than a short-term medicine. The NICE recommendation for semaglutide (TA875) notes treatment for up to two years within a specialist service, but clinical decisions about continuing or stopping should reflect your individual situation, not a fixed timetable.

Cost is a real factor for some people. If price is part of the conversation you are having, our Wegovy pricing page sets out what is typically included in private treatment costs. If you are spending time outdoors while on treatment, it is also worth reading about how Wegovy and sun exposure interact, since some people are not aware of the relevant considerations until they are caught out. Sometimes what looks like a stopping decision is really a question of sustainability, and that is worth exploring before committing either way.

If you are planning to stop, or already have and are noticing weight creeping back, a clinical review is the most useful next step. We would not suggest trying to manage this alone when a conversation with a prescriber can map out a clear plan. You can check your eligibility if you are considering starting, restarting or adjusting treatment with us.